intrinsic factor

Biologicalapproved

Approved

Jun 21, 1968

Intrinsic factor (IF), also known as cobalamin binding intrinsic factor, or gastric intrinsic factor (GIF), is a glycoprotein produced by the parietal cells (in humans) or chief cells (in rodents) of the stomach. It is necessary for the absorption of vitamin B12 later on in the distal ileum of the small intestine. In humans, the gastric intrinsic factor protein is encoded by the CBLIF gene. Haptocorrin (transcobalamin I) is another glycoprotein secreted by the salivary glands which binds to vitamin B12. Vitamin B12 is acid-sensitive and in binding to haptocorrin it can safely pass through the acidic stomach to the duodenum. — Wikipedia

Clinical trial activity

1 trials · 1 clinical orgs · 2 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2004 (NCT00279552)

Timeline

1960s

  1. Jun 21, 1968

    Mallinckrodt — Earliest FDA Approval

  2. Jun 21, 1968

    Mallinckrodt — NDA Secondary Org

  3. Jun 21, 1968

    Mallinckrodt — NDA Organization

1970s

  1. Dec 21, 1970

    Bracco — NDA Secondary Org

2000s

  1. Jan 1, 2004

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

Approval history

  • approvedJun 21, 1968

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Availability
Discontinued

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • gastric intrinsic factor
  • intrinsic factor
  • intrinsic factor
  • intrinsic factor
  • intrinsic factor

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00279552Phase 2Apr 1, 2004Aarhus University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Aarhus UniversityAcademic/Hospital1112004
1 organizations
Page 1 / 1

Marketing (3)

OrganizationOrg typeRelationshipDate
BraccoFor profitNDA2Dec 21, 1970
MallinckrodtFor profitNDA2Jun 21, 1968
MallinckrodtFor profitNDAJun 21, 1968